Psychiatry and Neurology, Neurology · Boston, MA
NPI
1497840177
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
15 Parkman Street Wac 835, Neurology Associates
Boston, MA, 02114
Phone (617) 726-1728
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
310 services
Medicare patients, 2024
50
Average age 58
Drug cost, 2024
$159K
729 prescriptions
Company payments, 2025
$19.62
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Herminia D Rosas was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 207 times for 40 patients. In total Herminia D Rosas billed 310 services in 7 codes, and Medicare paid $17K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 207 | 40 | $26.03 | $5,388 |
| 99215 Office E&M - Established | Office | 78 | 45 | $115.61 | $9,017 |
| 96116 Behavioral Health Services | Office | 15 | 15 | $75.51 | $1,133 |
By year: 2022 $15K for 224 services; 2023 $14K for 221 services; 2024 $17K for 310 services.
Medicare prescription drug claims, 2024
In 2024, the drug Herminia D Rosas prescribed most often to Medicare patients was Risperidone, with 89 prescriptions and refills. In total Herminia D Rosas wrote 729 Medicare prescriptions that cost $159K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Risperidone Generic | 89 | 157 | 13 | $1,278 |
| Aripiprazole Generic | 75 | 75 | Under 11 | $1,197 |
| Memantine Hcl Generic | 59 | 73 | Under 11 | $1,569 |
| Levothyroxine Sodium Generic | 41 | 59 | Under 11 | $374 |
| Levetiracetam Generic | 33 | 47 | Under 11 | $1,223 |
| Divalproex Sodium Generic | 32 | 48 | Under 11 | $1,614 |
| Trazodone Hcl Generic | 30 | 38 | Under 11 | $228 |
| Paroxetine Hcl Generic | 26 | 50 | Under 11 | $12K |
| Duloxetine Hcl Generic | 26 | 40 | Under 11 | $275 |
| Famotidine Generic | 24 | 48 | Under 11 | $214 |
| Austedo Deutetrabenazine | 24 | 24 | Under 11 | $126K |
| Fluoxetine Hcl Generic | 23 | 25 | Under 11 | $216 |
| Quetiapine Fumarate Generic | 20 | 21 | Under 11 | $130 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 17 | 27 | Under 11 | $410 |
| Clonazepam Generic | 16 | 24 | Under 11 | $39.26 |
Brand drugs: 53 claims; generic drugs: 676 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Herminia D Rosas $19.62 ($19.62 in general payments such as food, travel and fees) from 2 companies. The largest payer was Neurocrine BioSciences, Inc. with $19.62.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 1 | $19.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.